During the past decade, INVICTA Sp. Z o.o. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "INVICTA Sp. Z o.o." are "Uterine Fibroids" (3 trials), "Overactive Bladder" (1 trials), "Urinary Incontinence" (1 trials) and "Uterine Myomas" (1 trials). Many other conditions were trialed in "INVICTA Sp. Z o.o." in a lesser frequency.

Most popular intervention types in "INVICTA Sp. Z o.o." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "ELB245" (1 trials), "PGL4001" (1 trials), "PGL4001, placebo" (1 trials), "PGL4001, placebo, drug free period" (1 trials) and "PGL4001, progestin" (1 trials). Other intervention names were less common.

The vast majority of trials in "INVICTA Sp. Z o.o." are 4 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "INVICTA Sp. Z o.o.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in INVICTA Sp. Z o.o., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in INVICTA Sp. Z o.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".